Market Research Logo

Pharmaceuticals Global Industry Almanac 2013-2022

Pharmaceuticals Global Industry Almanac 2013-2022

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
  • Any currency conversions used in the production of this report have been calculated at constant 2017 annual average exchange rates.
  • The global pharmaceuticals market had total revenues of $1,066.5bn in 2017, representing a compound annual growth rate (CAGR) of 5.9% between 2013 and 2017.
  • Globally, both physicians and the public are much more accepting of generics than in previous years.
  • The US, China, and Japan are the largest global pharmaceutical markets followed by the four biggest European markets: Germany, France, Spain, and Italy. Amongst that number it is China that is producing the strongest growth every year, whilst the European states have been stifled due to current healthcare spending cultures in the region.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts
Reasons to buy
  • What was the size of the global pharmaceuticals market by value in 2017?
  • What will be the size of the global pharmaceuticals market in 2022?
  • What factors are affecting the strength of competition in the global pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the global pharmaceuticals market?


EXECUTIVE SUMMARY
Market value
Market value forecast
Geography segmentation
Market share
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global Pharmaceuticals
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Asia-Pacific
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Europe
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in France
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Germany
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Australia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Canada
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Indonesia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Italy
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Japan
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Mexico
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The Netherlands
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in North America
Market Overview
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Russia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Scandinavia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Singapore
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in South Africa
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in South Korea
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Spain
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Turkey
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The United Kingdom
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The United States
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading Companies
Appendix
Methodology
About MarketLine
List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 2013-17
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: Global pharmaceuticals market share: % share, by value, 2017
Table 4: Global pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 2013-17
Table 6: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2017
Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2017
Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2017-22
Table 9: Europe pharmaceuticals market value: $ billion, 2013-17
Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2017
Table 11: Europe pharmaceuticals market share: % share, by value, 2017
Table 12: Europe pharmaceuticals market value forecast: $ billion, 2017-22
Table 13: France pharmaceuticals market value: $ billion, 2013-17
Table 14: France pharmaceuticals market geography segmentation: $ billion, 2017
Table 15: France pharmaceuticals market share: % share, by value, 2017
Table 16: France pharmaceuticals market value forecast: $ billion, 2017-22
Table 17: France size of population (million), 2013-17
Table 18: France gdp (constant 2005 prices, $ billion), 2013-17
Table 19: France gdp (current prices, $ billion), 2013-17
Table 20: France inflation, 2013-17
Table 21: France consumer price index (absolute), 2013-17
Table 22: France exchange rate, 2013-17
Table 23: Germany pharmaceuticals market value: $ billion, 2013-17
Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2017
Table 25: Germany pharmaceuticals market share: % share, by value, 2017
Table 26: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Table 27: Germany size of population (million), 2013-17
Table 28: Germany gdp (constant 2005 prices, $ billion), 2013-17
Table 29: Germany gdp (current prices, $ billion), 2013-17
Table 30: Germany inflation, 2013-17
Table 31: Germany consumer price index (absolute), 2013-17
Table 32: Germany exchange rate, 2013-17
Table 33: Australia pharmaceuticals market value: $ billion, 2013-17
Table 34: Australia pharmaceuticals market geography segmentation: $ billion, 2017
Table 35: Australia pharmaceuticals market share: % share, by value, 2017
Table 36: Australia pharmaceuticals market value forecast: $ billion, 2017-22
Table 37: Australia size of population (million), 2013-17
Table 38: Australia gdp (constant 2005 prices, $ billion), 2013-17
Table 39: Australia gdp (current prices, $ billion), 2013-17
Table 40: Australia inflation, 2013-17
Table 41: Australia consumer price index (absolute), 2013-17
Table 42: Australia exchange rate, 2013-17
Table 43: Brazil pharmaceuticals market value: $ billion, 2013-17
Table 44: Brazil pharmaceuticals market geography segmentation: $ billion, 2017
Table 45: Brazil pharmaceuticals market share: % share, by value, 2017
Table 46: Brazil pharmaceuticals market value forecast: $ billion, 2017-22
Table 47: Brazil size of population (million), 2013-17
Table 48: Brazil gdp (constant 2005 prices, $ billion), 2013-17
Table 49: Brazil gdp (current prices, $ billion), 2013-17
Table 50: Brazil inflation, 2013-17
Table 51: Brazil consumer price index (absolute), 2013-17
Table 52: Brazil exchange rate, 2013-17
Table 53: Canada pharmaceuticals market value: $ billion, 2013-17
Table 54: Canada pharmaceuticals market geography segmentation: $ billion, 2017
Table 55: Canada pharmaceuticals market share: % share, by value, 2017
Table 56: Canada pharmaceuticals market value forecast: $ billion, 2017-22
Table 57: Canada size of population (million), 2013-17
Table 58: Canada gdp (constant 2005 prices, $ billion), 2013-17
Table 59: Canada gdp (current prices, $ billion), 2013-17
Table 60: Canada inflation, 2013-17
List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 2013-17
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: Global pharmaceuticals market share: % share, by value, 2017
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the global pharmaceuticals market, 2017
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2017
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2017
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2017
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2017
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2017
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2013-17
Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2017
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2017-22
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2017
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2017
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2017
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2017
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2017
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2017
Figure 21: Europe pharmaceuticals market value: $ billion, 2013-17
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 23: Europe pharmaceuticals market share: % share, by value, 2017
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2017-22
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2017
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2017
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2017
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2017
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2017
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2017
Figure 31: France pharmaceuticals market value: $ billion, 2013-17
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 33: France pharmaceuticals market share: % share, by value, 2017
Figure 34: France pharmaceuticals market value forecast: $ billion, 2017-22
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2017
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2017
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2017
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2017
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2017
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2017
Figure 41: Germany pharmaceuticals market value: $ billion, 2013-17
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 43: Germany pharmaceuticals market share: % share, by value, 2017
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2017
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2017
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2017
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2017
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2017
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2017
Figure 51: Australia pharmaceuticals market value: $ billion, 2013-17
Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 53: Australia pharmaceuticals market share: % share, by value, 2017
Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2017-22
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2017
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2017
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2017
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2017
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2017
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2017
Figure 61: Brazil pharmaceuticals market value: $ billion, 2013-17
Figure 62: Brazil pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 63: Brazil pharmaceuticals market share: % share, by value, 2017
Figure 64: Brazil pharmaceuticals market value forecast: $ billion, 2017-22
Figure 65: Forces driving competition in the pharmaceuticals market in Brazil, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report